Stratos BioCapital Announces the Launch of ImmunaGenix to Revolutionize Precision Immunotherapies
Stratos BioCapital is proud to announce the launch of ImmunaGenix, a next-generation biotech company focused on developing precision immunotherapies for autoimmune diseases and cancer. Backed by Stratos, ImmunoGenix is pioneering novel approaches to immune modulation, leveraging advanced antibody engineering and cellular therapy platforms. A New Era in ImmunotherapyImmunoGenix is dedicated to tackling some of the […]